Subscribe to all Fermentalg financial information by registering here.

  25/11/2016 18:00
Executive management strengthened:Philippe Lavielle appointed Chairman and CEO
  17/11/2016 18:00
Financial information at end-September 2016
  15/09/2016 18:00
H1 2016 results
  13/09/2016 18:00
Philippe Lavielle appointed Chairman of the Board of Directors
  21/07/2016 20:00
Activity in H1 2016
  20/06/2016 18:00
Optimized process book for DHA production is completed at Libourne
  23/05/2016 18:00
Board of Directors strengthened with the co-option of Philippe Lavielle
  17/05/2016 18:00
Production agreement with ARD marks a new milestone in the commercialization of DHA
  12/05/2016 18:30
Preparations for the commercialization of the first molecules in Q1 2016
  06/04/2016 12:00
2015 results, commercialization milestones and strategic roadmap

All publications will take place after the close of the Euronext markets in Paris.


 

Each PDF has been scanned by antimalware and incorporates a SECURITY MASTER Footprint. To check its authenticity:
www.security-master-footprint.com

Party powered automatically by Actusnews Wire ©
(Primary Information Provider)